Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. (Q35215812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

Peter W Szlosarek

1 reference

7 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

565-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

The TNF and TNF receptor superfamilies: integrating mammalian biology

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Identity of differentiation inducing factor and tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Clinical applications of TNF-alpha in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor or tumor promoting factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

TNF receptor subtype signalling: differences and cellular consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

TNF-R1 signaling: a beautiful pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Cytokines in non-genotoxic hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Enhancement of experimental metastasis by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Paradoxical effects of tumour necrosis factor in experimental ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Elevated circulating levels of tumor necrosis factor predict unresponsiveness to treatment with interferon alfa-2b in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Immunocytochemical increased evidence of inducible nitric oxide synthase, tumor necrosis factor-alpha, and adrenocorticotropic hormone in human peritumoral lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Endogenous tumor necrosis factor functions as a resistant factor against adriamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Activation of Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway by Tumor Necrosis Factor α Leads to Intercellular Adhesion Molecule-1 Expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Cachexia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Thalidomide: emerging role in cancer medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Cyclooxygenase-2: a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

A new function of green tea: prevention of lifestyle-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901196-3

7 January 2021

10.1016/S1470-2045(03)01196-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12965278%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference